Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash
Nicholas A. Trum, BS,
Jasmine Zain, MD,
Chelsea Abad, NP,
Steven T. Rosen, MD,
Christiane Querfeld, MD, PhD
Affiliations
Nicholas A. Trum, BS
Division of Dermatology, Beckman Research Institute, City of Hope Medical Center, Duarte, California; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
Jasmine Zain, MD
Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope Medical Center, Duarte, California
Chelsea Abad, NP
Division of Dermatology, Beckman Research Institute, City of Hope Medical Center, Duarte, California
Steven T. Rosen, MD
Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope Medical Center, Duarte, California; Beckman Research Institute, City of Hope Medical Center, Duarte, California
Christiane Querfeld, MD, PhD
Division of Dermatology, Beckman Research Institute, City of Hope Medical Center, Duarte, California; Department of Pathology, Beckman Research Institute, City of Hope Medical Center, Duarte, California; Beckman Research Institute, City of Hope Medical Center, Duarte, California; Correspondence to: Christiane Querfeld, MD, PhD, City of Hope and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA 91010.